24 related articles for article (PubMed ID: 9660540)
1. Combined Chemotherapy with Mitomycin C, Folinic Acid, and 5-Fluorouracil (MiFoFU) as Salvage Treatment for Patients with Liver Metastases from Breast Cancer - a Retrospective Analysis.
Eichbaum MH; Gast AS; Bruckner T; Schneeweiss A; Sohn C
Breast Care (Basel); 2008; 3(4):262-267. PubMed ID: 21076607
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of continuous mitomycin-C infusion in concomitant radiochemotherapy of primary inoperable advanced head and neck cancer.
Christiansen H; Hermann RM; Hille A; Schmidberger H; Martin A; Nitsche M; Hess CF; Pradier O
J Cancer Res Clin Oncol; 2005 Dec; 131(12):815-20. PubMed ID: 16142489
[TBL] [Abstract][Full Text] [Related]
3. Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.
Chong G; Dickson JL; Cunningham D; Norman AR; Rao S; Hill ME; Price TJ; Oates J; Tebbutt N
Br J Cancer; 2005 Sep; 93(5):510-4. PubMed ID: 16091760
[TBL] [Abstract][Full Text] [Related]
4. Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study.
Hartmann JT; Oechsle K; Quietzsch D; Wein A; Hofheinz RD; Honecker F; Nehls O; Köhne CH; Käfer G; Kanz L; Bokemeyer C
Br J Cancer; 2003 Dec; 89(11):2051-6. PubMed ID: 14647137
[TBL] [Abstract][Full Text] [Related]
5. Activity of boanmycin against colorectal cancer.
Deng YC; Zhen YS; Zheng S; Xue YC
World J Gastroenterol; 2001 Feb; 7(1):93-7. PubMed ID: 11819740
[No Abstract] [Full Text] [Related]
6. Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
Propper DJ; Levitt NC; O'Byrne K; Braybrooke JP; Talbot DC; Ganesan TS; Thompson CH; Rajagopalan B; Littlewood TJ; Dixon RM; Harris AL
Br J Cancer; 2000 Jun; 82(11):1776-82. PubMed ID: 10839290
[TBL] [Abstract][Full Text] [Related]
7. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
8. Evaluating cost-effectiveness in outpatient management of medical complications in cancer patients.
Rubenstein EB
Curr Opin Oncol; 1998 Jul; 10(4):297-301. PubMed ID: 9702396
[TBL] [Abstract][Full Text] [Related]
9. Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer.
Hartmann JT; Quietzsch D; Daikeler T; Kollmannsberger C; Mayer F; Kanz L; Bokemeyer C
Anticancer Drugs; 1999 Sep; 10(8):729-33. PubMed ID: 10573205
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma.
Hartmann JT; Kanz L; Bokemeyer C
Anticancer Res; 2000; 20(2B):1177-82. PubMed ID: 10810418
[TBL] [Abstract][Full Text] [Related]
11. Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
Hartmann JT; Köhne CH; Schmoll HJ; Daikeler T; Kanz L; Bokemeyer C
Oncology; 1998; 55(4):320-5. PubMed ID: 9663421
[TBL] [Abstract][Full Text] [Related]
12. Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
Conti JA; Kemeny NE; Saltz LB; André AM; Grossano DD; Bertino JR
Cancer; 1995 Feb; 75(3):769-74. PubMed ID: 7828126
[TBL] [Abstract][Full Text] [Related]
13. A dose-escalation phase II clinical trial of infusional mitomycin C for 7 days in patients with advanced measurable colorectal cancer refractory or resistant to 5-fluorouracil.
Anderson N; Lokich J; Moore C; Bern M; Coco F
Cancer Invest; 1999; 17(8):586-93. PubMed ID: 10592766
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer.
Hartmann JT; Harstrick A; Daikeler T; Kollmannsberger C; Müller C; Seeber S; Kanz L; Bokemeyer C
Anticancer Drugs; 1998 Jun; 9(5):427-31. PubMed ID: 9660540
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]